MT
Mediar Therapeutics, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$37.8Msold at filing
Total offering$75.7M$37.8M still open
Investors in the raise18count reported to the SEC
FiledDec 23, 2025first sale Dec 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andreas JurgeitDirector
Bharat SrinivasaDirector
Allan MarchingtonDirector
Rahul BallalExecutive Officer, Director
Cassidy BlundellDirector
Maina BhamanDirector
Adam CottonDirector
Simon SturgeDirector
Marie-Claire PeakmanDirector
Executive officers, directors and promoters as listed on the Form D.